Basic Information
| LncRNA/CircRNA Name | circU2AF1 |
| Synonyms | circ_0061868 |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | glioma |
| ICD-0-3 | NA |
| Methods | Apoptosis assay, Cell cycle assay, Migration and invasion assays, qRT??CR, Western blot, Dual luciferase activity assay, Biotin pull down assay, In vivo xenografting |
| Sample | primary glioma tissue, glioma cell lines U87MG and U251 and the normal glial cell line HE |
| Expression Pattern | up-regulated |
| Function Description | the expression levels of circ-U2AF1 and NOVA2 were upregulated, while hsa-miR-7-5p was downregulated in human glioma tissues and glioma cell lines. Our data and bioinformatic analysis indicated the association of these molecules with glioma grade, a positive correlation between circ-U2AF1 and NOVA2 expression levels and a negative correlation of hsa-miR-7-5p with both circ-U2AF1 and NOVA2, respectively. In addition, silencing of circ-U2AF1 expression resulted in increased hsa-miR-7-5p expression and decreased NOVA2 expression both in vitro and in vivo. Luciferase assay confirmed hsa-miR-7-5p as a direct target of circ-U2AF1 and NOVA2 as a direct target of hsa-miR-7-5p. Functionally, silencing of circ-U2AF1 inhibits glioma development by repressing NOVA2 via upregulating hsa-miR-7-5p both in vitro and in vivo. |
| Pubmed ID | 30341906 |
| Year | 2018 |
| Title | Circ??2AF1 promotes human glioma via derepressing neuro??ncological ventral antigen 2 by sponging hsa??iR????p |
External Links
| Links for circU2AF1 | GenBank HGNC NONCODE |
| Links for glioma | OMIM COSMIC |